Skip links

No relief from deeming regs as US Senate approves key spending bill

The industry’s hopes that a US federal spending bill would reduce the impact of the Food and Drug Administration’s (FDA’s) deeming regulations were disappointed this week when a Senate committee approved a version that makes no reference to tobacco products. Passed unanimously by the Senate Appropriations Committee, the measure remained silent not only on e-cigarettes but on tobacco products in general.

Restricted content. Do you want to read more?